No Data
No Data
Third Harmonic Bio Releases New Corporate Presentation
Third Harmonic Bio Q1 2024 Adj EPS $(0.20) Beats $(0.31) Estimate
Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.31) by 35.48 percent.
Third Harmonic Bio 1Q Research and Development Expenses $6.2M >THRD
Third Harmonic Bio 1Q Research and Development Expenses $6.2M >THRD
Third Harmonic Bio | 10-Q: Quarterly report
Third Harmonic Bio 1Q EPS 20c >THRD
Third Harmonic Bio 1Q EPS 20c >THRD
Insider Sale: CEO Natalie Holles Sells Shares of Third Harmonic Bio Inc (THRD)